Botox, Dysport, or Jeuveau: Does the Brand Actually Matter?

Somewhere between the group chat and the consultation chair, the brand question always comes up. Your friend swears by Dysport. The med spa down the street is pushing Jeuveau. Your mom has only heard of Botox and thinks the rest sound like knockoffs. So which one wins?

Here’s the honest answer, up front: the differences between these three are real, but they’re small, and they matter far less than who is holding the syringe. All three are prescription medications that a licensed, trained medical provider has to evaluate you for and administer — this isn’t a product you shop for, it’s a treatment you consent to. An injector who knows facial anatomy cold will get you a better result with their second-favorite brand than a rushed one will with your favorite. The brand debate is mostly marketing. Here’s why, plus the differences that genuinely matter.

Same molecule, same job

Start with what isn’t different, because it’s most of it. Botox, Dysport, and Jeuveau are all botulinum toxin type A, and they work the same way: injected into a muscle, they temporarily interrupt the nerve signal telling that muscle to contract. The muscle relaxes, it stops folding the skin above it, and the crease softens. That’s the whole mechanism. It’s a muscle story, not a skin story.

Where they differ is formulation — each is made by a different company using a different process, with its own protein load, stabilizers, and dosing scale. Those differences generate the marketing claims. They aren’t different drugs doing different things.

The three, side by side

Botox is the one everyone knows, and the name has become genericized shorthand the way Kleenex did. Its generic name is onabotulinumtoxinA, and it’s made by Allergan, now part of AbbVie. It has been on the market the longest of the three, which means the deepest track record and the widest range of approved uses — not just cosmetic, but therapeutic ones including chronic migraine, muscle spasticity, and excessive sweating. When an injector mentions a brand having “the most data,” this is the one.

Dysport is abobotulinumtoxinA, developed by Ipsen and marketed in the U.S. by Galderma. It has long been used in Europe, is thoroughly established here too, and carries therapeutic approvals alongside its cosmetic one. Two things get repeated about it constantly — that it spreads a bit more and kicks in a bit faster — and both get badly oversimplified, so both get their own section below.

Jeuveau is the newest, prabotulinumtoxinA, made by Evolus and nicknamed “Newtox” almost immediately. It was built and positioned as an aesthetic product, which carries a practical consequence: Jeuveau is approved for cosmetic use only — specifically the frown lines between the brows — and doesn’t carry the therapeutic approvals Botox does. If your injector has been treating your migraines or your sweating alongside your forehead, that’s not academic. For a purely cosmetic patient, it changes very little.

What’s actually in the vial

Botulinum toxin doesn’t arrive as a bare molecule. In Botox and Dysport, the active neurotoxin comes packaged with accessory proteins — sometimes called complexing proteins — that naturally associate with it and carry through into the finished product. Xeomin is the outlier, purified so those proteins are stripped out, which is where the “naked toxin” nickname comes from. Each manufacturer runs its own process, so the protein load isn’t identical across products.

What that means for your forehead is less than the marketing implies. The argument goes that extra proteins give the immune system more to react to, and that a formulation without them might be less likely to provoke a response over years. It’s plausible, it gets made confidently, and it isn’t settled. Treat it as an open question, not a selling point. Formulation does show up in one practical conversation, though: Dysport’s molecular profile is frequently invoked to explain why it’s described as spreading a little more. That’s probably part of the story and certainly not all of it.

While we’re here, the fifth name you may hear quoted is Daxxify, daxibotulinumtoxinA, a peptide-based formulation marketed on a longer-lasting result. Along with Xeomin it’s a legitimate option if your injector works with it, and neither changes the point of this post.

Why “more units” doesn’t mean more product

This is the most important thing in this post, and the thing that trips up the most people. Units aren’t interchangeable between brands. A unit of Dysport isn’t a unit of Botox. The scales were set separately by separate manufacturers, and the conversion commonly cited in clinical practice falls somewhere around two and a half to three Dysport units for every one Botox unit — though the figure varies by injector, by treatment area, and by which source you’re reading. It’s a rule of thumb, not a formula, and your injector does the conversion.

So if a Dysport quote uses a much larger unit number than you’re used to hearing, that’s expected, and it doesn’t mean a stronger dose. It also makes per-unit price comparisons across brands meaningless. To compare clinics, compare what a full treatment of an area costs — and note that some practices price by unit and some by area, which muddies it further.

Don’t do this math yourself. Not to check your injector, not to compare quotes, not to decide what you “should” be getting. Dosing is a clinical decision made by a licensed provider looking at your specific muscles, and a ratio pulled off the internet is no substitute. Ask what they’re using and why instead.

Spread and speed: the two differences injectors actually debate

Dysport is generally described as diffusing a little more from the injection point. Some injectors like that: across a broad, flat area like the forehead, a product that spreads can soften the patchy look you get when relaxed and unrelaxed zones sit side by side. Others want tight control — around the eyes, near the brow, anywhere a millimeter of unintended spread changes the outcome.

Treat that as a tendency your injector weighs, not a hard rule. A skilled injector can work precisely with a spreadier product, and a careless one can get spread out of any of them.

Onset is the other. Dysport is often reported to show up slightly sooner — a couple of days rather than several — while all three generally take a week or two to settle. If you have something on the calendar, that head start might matter. Otherwise it’s a footnote, and plenty of people notice no difference at all.

The dilution problem nobody mentions

Here’s the variable that quietly undermines every brand comparison you’ll read, this one included. These products arrive as a powder, and before anything is injected the provider reconstitutes the vial with saline. How much saline is a judgment call, not a fixed recipe.

More diluent generally means a larger volume carrying the same dose, and larger volumes are commonly described as travelling further from where they land. Less diluent, the reverse. So two injectors using the same brand can produce noticeably different spread, and one injector can make a product behave more like its competitor just by changing the mix. Which means a good share of what patients experience as a brand difference is really a dilution or placement difference. That’s this post’s thesis arriving from another direction — and it explains why the same brand can feel different at two clinics, and why your friend’s glowing review of a product may really be a review of her injector.

Which lines are on the label, and which aren’t

The frown lines between the brows — the glabellar lines, the “elevens” — are the cosmetic indication these products have in common. Past that it gets uneven: forehead lines and crow’s feet aren’t approved uniformly across products, and specifics differ brand to brand. Rather than trusting a list you found online, ask your injector what the product they’re proposing is approved for in the area you care about.

Which raises the word that makes people nervous: off-label. Plenty of real-world cosmetic injecting sits outside a product’s formal approval, and that’s legal, routine, and not a red flag on its own — physicians prescribe off-label across medicine when evidence and judgment support it. It does mean the depth of evidence varies by area, so a provider’s experience carries even more weight than usual. Ask what’s on-label, what isn’t, and what they’ve seen.

How to actually pick one

Pick the injector first. Then use whatever that injector uses most.

That sounds like a dodge and it isn’t. Someone who has placed a product thousands of times knows its dilution and its spread in a way no comparison chart can encode, and that fluency is worth more to your face than any listed advantage of a different brand.

So ask. The answer tells you about the product and about whether this person thinks in terms of anatomy or promotions. A thoughtful injector will have a reason, will mention your particular muscles, and may suggest different products for different areas of the same face.

A few things not to do. Don’t brand-shop between clinics chasing the name your friend liked; you’ll pick an injector for the wrong reason. Don’t switch to chase a deal. And if you do switch, give the new one a full cycle before deciding — one round with a new product and possibly a new dose isn’t a fair test. If the result missed, say so at your follow-up rather than quietly defecting.

What to ask before anyone injects anything

A consultation is a two-way interview. Bring these.

Which product would you use on me, and why that one for my anatomy? You want a reason tied to your muscles, not to what’s on promotion. How many units, and how does that convert if I’ve been treated with a different brand? Let them do the conversion — you’re asking to understand, not to audit. What’s your plan for the two-week check? A provider who builds in a follow-up is a provider who expects to fine-tune. What happens if I want an adjustment? Ask how touch-ups are handled before your appointment, not after. Will you be injecting, or is it delegated? Perfectly reasonable to ask, and the answer should come easily. What’s your complication protocol? Anyone experienced has seen a droopy lid and can tell you calmly what they do about it. Hesitation on that last one tells you something.

Give it the full two weeks

The most common patient mistake has nothing to do with brands. It’s judging the result on day four. These products take time to take hold, and the in-between stretch can look uneven as different muscles let go at different rates. Panicking then is what leads people to demand more product, switch clinics, or write off a brand that was working fine.

That’s what the two-week check exists for. A touch-up at that point is a small, deliberate adjustment to something that has fully settled, not a rescue mission. One note on symmetry: no face is symmetrical to begin with, and chasing perfect balance with more product tends to trade a small unevenness for a heavier, flatter look. Good injectors leave a little asymmetry alone.

Does it stop working over time?

When a product that used to work seems not to anymore, the word reached for is resistance. The underlying phenomenon is real — the body can in some cases form neutralizing antibodies to botulinum toxin, which would blunt the effect. It’s also uncommon, discussed far more than it’s settled, and it comes up mostly around frequent, high-dose therapeutic treatment rather than typical cosmetic intervals.

Before landing there, consider the mundane explanations, because they account for most cases: a smaller dose than last time, slightly different placement, a longer gap since the last appointment than you remember, or expectations that drifted upward while the result stayed the same. Comparing a fresh two-week photo against an old two-week photo, rather than against memory, settles a surprising amount of this. If it genuinely isn’t working, that’s a conversation with your provider, not a reason to brand-hop.

Four things people believe that aren’t true

That it builds up in your system. It doesn’t pool somewhere waiting to be released; the effect on a treated muscle fades, which is exactly why the appointment repeats. What can build over years is the habit of not creasing an area as hard — a different thing entirely.

That it inevitably freezes your face. A frozen look is a dose-and-placement outcome, not an inherent property of any of these products. Too much in the wrong spot reads flat no matter what’s on the vial.

That it’s dangerous because it comes from a toxin. Dose and context are the whole story, as with most medications. It’s still a prescription drug for a reason, and the safety argument rests on a trained provider using a properly sourced product.

That a lower per-unit price is a better deal. Units don’t convert across brands, so a cheaper unit can easily be a smaller unit. Compare treatments, never units.

What can go wrong, and who should wait

These are used widely and considered safe in trained hands, and none of that makes them risk-free. Common side effects are minor and short-lived: bruising and tenderness at the injection sites, a headache in the day or two after, sometimes swelling. Bruising is the one most people run into, and it’s cosmetic rather than dangerous.

The ones worth understanding before you book involve product reaching a muscle it wasn’t meant to reach. A temporarily droopy eyelid or a heavy, dropped brow (ptosis) can happen when product spreads nearby, and while it resolves as the effect wears off, that can mean weeks of looking not quite like yourself. Asymmetry is possible too, often correctable with a small adjustment at a follow-up. Everything here is temporary in both directions — a bad result isn’t permanent, and a good one isn’t either.

Rare but serious effects do exist. Botulinum toxin products carry a class warning about the toxin’s effects spreading beyond the injection site, with symptoms that can include trouble swallowing or breathing. It’s uncommon, and it’s exactly why these are prescription drugs restricted to trained providers. That training is the safety mechanism, not a formality.

Some people should hold off, or at least talk it through first. Neurotoxin treatment isn’t recommended during pregnancy or breastfeeding. Certain neuromuscular conditions, including myasthenia gravis and related disorders, are reasons to discuss suitability with a physician before anything is injected, as are an active infection at the treatment site or a past poor reaction. Bring your full medication and supplement list as well — certain drugs, including some antibiotics that affect neuromuscular transmission, can interact, and anything that thins the blood raises the odds of bruising. Recent facial surgery, an unhealed procedure in the area, or a period when you can’t spare two weeks for a result to settle are all reasonable grounds to postpone. Nothing here is medical advice — talk to a licensed medical provider about your own health, your medications, and whether this is appropriate for you at all. Our skin archive is a good place to keep reading.

The brands at a glance

What we actually keep on the shelf between appointments

To be clear about this list: none of these replace, replicate, or extend a neurotoxin. Nothing sold on Amazon does. What the shelf can do is support the skin sitting over those muscles — sun protection, barrier care, and the comfort items people reach for around an appointment. These are affiliate links, so a purchase may earn us a small commission at no extra cost to you.

Prices move constantly, so we link to live listings instead of printing a number that is wrong by the time you read it. Links go to Amazon, which is where a referral gets credited.

Questions people ask

Is one of these three better than the others? No, and anyone telling you otherwise is selling something. They’re broadly comparable products doing the same thing with slightly different formulations. Preference comes down to injector experience and personal response, not a ranking.

Why did my Dysport quote have so many more units? Because Dysport is measured on a different unit scale. A larger number is expected and doesn’t mean a stronger dose. It also means per-unit prices can’t be meaningfully compared across brands.

Is Jeuveau a knockoff of Botox? No. It’s a separate product from a separate manufacturer with its own approval, positioned as a cosmetic-only option. It was priced to compete — a business decision, not a statement about the product.

Who shouldn’t get any of them? Anyone pregnant or breastfeeding, anyone with certain neuromuscular conditions, anyone with an active infection at the treatment site, and anyone with a past bad reaction should talk it through with a physician first. It’s a medical decision, and it belongs with a licensed provider who knows your history.

One last thing

The brand question feels important because it’s the only variable that’s easy to research. You can read about Botox and Dysport and Jeuveau from your couch. Working out whether an injector understands the muscles under your forehead is much harder, so people skip that and optimize the easy thing instead.

Optimize the hard thing. Find someone with real training, real volume, and a habit of asking what you want your face to do before they pick up a needle. Then let them use what they use. The name on the vial should be the least interesting part of your result.